Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H21ClN2O2 |
| Molecular Weight | 284.782 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCCC\C(C1=CC=C(Cl)C=C1)=N/OCCN
InChI
InChIKey=XXPVSQRPGBUFKM-SAPNQHFASA-N
InChI=1S/C14H21ClN2O2/c1-18-10-3-2-4-14(17-19-11-9-16)12-5-7-13(15)8-6-12/h5-8H,2-4,9-11,16H2,1H3/b17-14+
| Molecular Formula | C14H21ClN2O2 |
| Molecular Weight | 284.782 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Clovoxamine is an antidepressant and anxiolytic drug, acting as a serotonin and norepinephrine reuptake inhibitor. The drug was investigated in the double-blind clinical trials for the treatment of anxiety neurosis, where it was compared with diazepam, and found to have comparable efficacy but higher drop out rate.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:42:37 GMT 2025
by
admin
on
Mon Mar 31 18:42:37 GMT 2025
|
| Record UNII |
7I22J7RY2A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
36813
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
3880
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
C020724
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
100000084035
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
54739-19-4
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
C78003
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
6335903
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
DTXSID501023903
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
SUB06778MIG
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
CLOVOXAMINE
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
7I22J7RY2A
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105603
Created by
admin on Mon Mar 31 18:42:37 GMT 2025 , Edited by admin on Mon Mar 31 18:42:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
